Popular
Having trouble identifying your medications? Try the Pill Identifier
Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.
Get StartedFeatured Tool
Worried about drug interactions? Use the Interactions Checker
The drug interactions tool allows you to check for drug-drug and drug-food interactions.
Check NowFeatured Tool
Discover treatment options with the Symptom Checker
This interactive decision guide helps identify the underlying cause of common symptoms.
Get StartedFeatured Tool
Custom search for Medical Transcriptionists?
Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.
Get StartedDrug Information
- A to Z Drug List
- Drugs by Condition
- Drugs by Class
- Dosage
- Side Effects
- Pregnancy Warnings
- Harvard Health Guide
- Generic Drugs
- OTC Database
- Inactive Ingredients
- Veterinary Drugs
- International Drugs
- Info en Español
- Pricing & Coupon Guide
Tools
- Interactions Checker
- Pill Identifier
- Symptom Checker
- Medication Record
- Mobile Apps
- Drug Imprint Codes
- Forums
- Q&A - FAQ
- Compare Drugs
News & Alerts
- Medical News
- Clinical Trial Results
- FDA Drug Alerts
- FDA Consumer Updates
- New FDA Approvals
- New Drug Applications
- Drug Shortages
- Video Center
- Popular Articles
- Health & Medication Slideshows
Professionals
Top 100 Drugs
- Abilify
- Acetaminophen
- Adderall
- Advair
- Albuterol
- Alprazolam
- Ambien
- Amitriptyline
- Amlodipine
- Amoxicillin
- Aspirin
- Ativan
- Atorvastatin
- Augmentin
- Azithromycin
- Baclofen
- Benadryl
- Byetta
- Bydureon
- Celebrex
- Celexa
- Cephalexin
- Cetirizine
- Cialis
- Ciprofloxacin
- Citalopram
- Clindamycin
- Clonazepam
- Clonidine
- Cymbalta
- Diazepam
- Diclofenac
- Dilaudid
- Doxycycline
- Effexor
- Escitalopram
- Fenofibrate
- Flexeril
- Fluoxetine
- Gabapentin
- Hydroxyzine
- Ibuprofen
- Januvia
- Klonopin
- Lamictal
- Levothyroxine
- Lexapro
- Lipitor
- Lisinopril
- Loratadine
- Lorazepam
- Losartan
- Lyrica
- Meloxicam
- Metformin
- Methadone
- Metoprolol
- Metronidazole
- Morphine
- Mucinex
- Naproxen
- Neurontin
- Nexium
- Norco
- Omeprazole
- Ondansetron
- Oxycodone
- Oxycontin
- Pantoprazole
- Paroxetine
- Penicillin
- Percocet
- Phentermine
- Pravastatin
- Prednisone
- Propranolol
- Prozac
- Risperdal
- Ritalin
- Seroquel
- Sertraline
- Simvastatin
- Suboxone
- Symbicort
- Synthroid
- Tamsulosin
- Tramadol
- Trazodone
- Tylenol
- Valium
- Venlafaxine
- Viagra
- Vicodin
- Victoza
- Vyvanse
- Warfarin
- Xanax
- Xarelto
- Zofran
- Zoloft
- Zolpidem
- Zyrtec
- MedFacts Drug Information
- Cerner Multum Drug Information
- Micromedex® Advanced Consumer
- MedFacts Natural Products
- Luxturna Luxturna (voretigene neparvovec) is an adeno-associated viral (AAV) vector gene therapy for the treatment of patients with vision loss due...
- Rhopressa Rhopressa (netarsudil ophthalmic solution) is a Rho kinase inhibitor for the treatment of open-angle glaucoma or ocular hypertension.
- Eskata Eskata (hydrogen peroxide) 40% (w/w) topical solution is a high-concentration hydrogen peroxide formulation for the treatment of raised...
- patisiran Patisiran is an investigational RNAi therapeutic targeting transthyretin (TTR) in development for the treatment of hereditary ATTR (hATTR)...
- galcanezumab Galcanezumab is a calcitonin gene-related peptide (CGRP) receptor antagonist in development for the prevention of migraine and cluster...
- TPOXX TPOXX (tecovirimat) is an oral and IV formulation antiviral drug in development for the treatment of smallpox and other orthopoxvirus...
Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
Posted today in New Drug Approvals
FDA Approves Luxturna (voretigene neparvovec-rzyl) Gene Therapy to Treat Patients with a Rare Form of Inherited Vision Loss
The U.S. Food and Drug Administration today approved Luxturna (voretigene neparvovec-rzyl), a new gene therapy, to treat children and adult patients with an inherited form of vision loss that may result in blindness. Luxturna is the first directly administered gene therapy approved in the U.S. that targets a disease caused by mutations in a specific...
Posted today in Clinical Trials
Blueprint Medicines Announces New Data from Ongoing Phase 1 Clinical Trial of Avapritinib (BLU-285) in Patients with Advanced Systemic Mastocytosis Showing Evidence of Strong Clinical Activity
Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced new data from its ongoing Phase 1 clinical trial of avapritinib (formerly known as BLU-285), a potent and highly selective KIT and PDGFRα inhibitor in development for patients...
Featured Topic Centers
Posted today in Medical
FDA Approves Gene Therapy, Luxturna (Voretigene Neparvovec-rzyl) for Rare Form of Blindness

Posted 2 days ago in New Drug Approvals
Aclaris Therapeutics Receives FDA Approval for Eskata (hydrogen peroxide) Topical Solution, 40% (w/w) for the Treatment of Raised Seborrheic Keratoses
Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Eskata (hydrogen peroxide) topical solution, 40% (w/w) for the treatment of raised seborrheic keratoses, or SKs. SKs are non-cancerous skin growths that affect more than 83 million American...
Posted today in Medical
Heroin Vaccine Blunts Drug's Effect in Animals

Posted today in Medical
Cancer Survivors Often Face Another Hurdle: Faster Aging

Posted today in Medical
Gene Therapy, Luxturna (Voretigene Neparvovec-rzyl), Approved for Rare Inherited Vision-Loss Disorders
Luxturna, a form of gene therapy, has been approved to treat a rare group of inherited vision disorders that can lead to blindness. The disorders are broadly grouped together and known as biallelic RPE65 mutation-associated retinal dystrophy. They affect a combined 1,000 to 2,000 people in the United States, the U.S. Food and Drug Administration said...
Posted today in Medical
U.S. Lifts Ban on Laboratory-Made Lethal Viruses

Posted today in New Drug Approvals
Aerie Pharmaceuticals Announces U.S. FDA Approval of Rhopressa (netarsudil ophthalmic solution) 0.02% for Patients with Open-Angle Glaucoma or Ocular Hypertension
(BUSINESS WIRE)--Dec. 18, 2017-- Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), an ophthalmic pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced that the U.S. Food and Drug...
Posted 2 days ago in Medical
Tougher State Laws Curb Vaccine Refusers

Recently added consumer and prescribing information: Ozempic, Juluca, Hemlibra, Prevymis, Fasenra, Calquence, Yescarta, Verzenio, Trelegy Ellipta, Solosec
Posted in Blog
Drugs.com Receives eHealthcare Leadership Silver Award
We are proud to announce that Drugs.com has been awarded a Silver Award for “Best Consumer General Health Site” in the 2017 eHealthcare Leadership Awards. Jane Weber Brubaker, chair of the eHealthcare Leadership Awards, notes that “Winners range from small and large healthcare provider organizations, to business-to-business and medical device companies, but they share these […]
Posted in Blog
Drugs.com Recognized as ‘Health Information Website Brand of the Year’ in 2017 Harris Poll EquiTrend® Study
The team at Drugs.com is humbled and heartened to have been recognized as the ‘Health Information Website Brand of the Year‘ in the 2017 Harris Poll EquiTrend Study. The annual Harris Poll EquiTrend® Study measures and compares a brand’s health over time and against key competitors. Other categories measured include travel, financial, automotive and entertainment. […]
Posted in Blog
REMS@FDA: An Upgraded Patient Safety Program
REMS Overview Fact: Prescription drugs are complicated, and they are getting more complicated every day. Issues with complex drugs and side effects is not just a concern for the healthcare provider, it directly impacts the patient and caregiver, too. We’ve all heard the long list of adverse effects and warnings that unfold during a primetime […]
